Anticholinergic-Containing Drugs has 2 known drug interactions based on U.S. FDA drug labeling data. 1 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Ipratropium Bromide Inhalation, Revefenacin. Patients taking Anticholinergic-Containing Drugs should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 2
- Major
- 1
- Moderate
- 1
Major (1)
- Anticholinergic-Containing Drugs + Ipratropium Bromide Inhalation— Avoid coadministration with other anticholinergic-containing drugs due to potential additive interaction that may lead t…
Moderate (1)
- Anticholinergic-Containing Drugs + Revefenacin— May interact additively with revefenacin, leading to increased anticholinergic adverse effects. Avoid coadministration.